<bill session="117" type="h" number="467" updated="2023-01-11T13:43:29Z">
  <state datetime="2021-01-25">REFERRED</state>
  <status>
    <introduced datetime="2021-01-25"/>
  </status>
  <introduced datetime="2021-01-25"/>
  <titles>
    <title type="display">Protecting Patient Access to Lifesaving COVID&#226;&#8364;&#8220;19 Drugs Act of 2021</title>
    <title type="official" as="introduced">To amend the Families First Coronavirus Response Act and the CARES Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage, without cost sharing, of certain COVID-19 antibody treatments.</title>
    <title type="short" as="introduced">Protecting Patient Access to Lifesaving COVID&#226;&#8364;&#8220;19 Drugs Act of 2021</title>
  </titles>
  <sponsor bioguide_id="G000588"/>
  <cosponsors>
    <cosponsor bioguide_id="G000583" joined="2021-08-17"/>
    <cosponsor bioguide_id="J000032" joined="2021-02-04"/>
    <cosponsor bioguide_id="N000191" joined="2021-06-14"/>
    <cosponsor bioguide_id="R000305" joined="2021-04-30"/>
    <cosponsor bioguide_id="R000577" joined="2021-03-23"/>
    <cosponsor bioguide_id="S001209" joined="2021-01-25"/>
  </cosponsors>
  <actions>
    <action datetime="2021-01-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-01-25" state="REFERRED">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-01-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-01-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-01-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-02-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSED" name="House Education and the Workforce" subcommittee="" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Drug therapy"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
  </subjects>
  <amendments/>
  <summary date="2021-04-07T20:28:14Z" status="Introduced in House">Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021

This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.</summary>
</bill>
